Annual Accounts Payable
$2.14 M
+$1.73 M+412.68%
December 31, 2023
Summary
- As of February 7, 2025, APGE annual accounts payable is $2.14 million, with the most recent change of +$1.73 million (+412.68%) on December 31, 2023.
- During the last 3 years, APGE annual accounts payable has risen by +$1.73 million (+412.68%).
- APGE annual accounts payable is now at all-time high.
Performance
APGE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.22 M
-$3.31 M-59.91%
September 30, 2024
Summary
- As of February 7, 2025, APGE quarterly accounts payable is $2.22 million, with the most recent change of -$3.31 million (-59.91%) on September 30, 2024.
- Over the past year, APGE quarterly accounts payable has increased by +$73.00 thousand (+3.41%).
- APGE quarterly accounts payable is now -80.12% below its all-time high of $11.15 million, reached on June 30, 2023.
Performance
APGE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
APGE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +412.7% | +3.4% |
| 3 y3 years | +412.7% | -80.1% |
| 5 y5 years | +412.7% | -80.1% |
APGE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +412.7% | -80.1% | +430.1% |
| 5 y | 5-year | at high | +412.7% | -80.1% | +430.1% |
| alltime | all time | at high | +412.7% | -80.1% | +430.1% |
Apogee Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.22 M(-59.9%) |
| Jun 2024 | - | $5.53 M(+28.5%) |
| Mar 2024 | - | $4.30 M(+100.7%) |
| Dec 2023 | $2.14 M | $2.14 M(+77.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.21 M(-89.2%) |
| Jun 2023 | - | $11.15 M(+1055.2%) |
| Mar 2023 | - | $965.00 K(+130.9%) |
| Dec 2022 | $418.00 K | $418.00 K |
FAQ
- What is Apogee Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Apogee Therapeutics?
- What is Apogee Therapeutics annual accounts payable year-on-year change?
- What is Apogee Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly accounts payable year-on-year change?
What is Apogee Therapeutics annual accounts payable?
The current annual accounts payable of APGE is $2.14 M
What is the all time high annual accounts payable for Apogee Therapeutics?
Apogee Therapeutics all-time high annual accounts payable is $2.14 M
What is Apogee Therapeutics annual accounts payable year-on-year change?
Over the past year, APGE annual accounts payable has changed by +$1.73 M (+412.68%)
What is Apogee Therapeutics quarterly accounts payable?
The current quarterly accounts payable of APGE is $2.22 M
What is the all time high quarterly accounts payable for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly accounts payable is $11.15 M
What is Apogee Therapeutics quarterly accounts payable year-on-year change?
Over the past year, APGE quarterly accounts payable has changed by +$73.00 K (+3.41%)